(Q38295771)

1 September 2017

1 reference

title

Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls (English)

1 reference

1 September 2017

1 reference

Mohan Babu Appaiahgari

series ordinal

1

1 reference

1 September 2017

Sudhanshu Vrati

series ordinal

2

1 reference

1 September 2017

language of work or name

English

0 references

publication date

22 December 2014

1 reference

Expert Opinion on Biological Therapy

1 September 2017

published in

1 reference

1 September 2017

volume

15

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

337-351

1 reference

Virus-mediated gene delivery for human gene therapy

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenoviruses: update on structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Latest insights on adenovirus structure and assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Advances and future challenges in adenoviral vector pharmacology and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Viruses - from pathogens to vaccine carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

The influence of innate and pre-existing immunity on adenovirus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

From the first to the third generation adenoviral vector: what parameters are governing the production yield?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Cancer selective adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Increasing the efficacy of oncolytic adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Trial Watch:: Oncolytic viruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Gene therapy for cystic fibrosis: which postman, which box?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Cardiovascular gene therapy with vascular endothelial growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Current issues and future directions of oncolytic adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Tropism-modification strategies for targeted gene delivery using adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Current advances and future challenges in Adenoviral vector biology and targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

The adenovirus capsid: major progress in minor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

LH3, a "homologue" of the mastadenoviral E1B 55-kDa protein is a structural protein of atadenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Computationally designed adeno-associated virus (AAV) Rep 78 is efficiently maintained within an adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Development of hybrid viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Novel integrating adenoviral/retroviral hybrid vector for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adeno-associated virus: a key to the human genome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Integration specificity of phage phiC31 integrase in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Oncolytic viruses as anticancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Association of oncolytic adenoviruses with chemotherapies: an overview and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Development of adenovirus capsid proteins for targeted therapeutic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Tumor detection and elimination by a targeted gallium corrole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

A mechanistic study of tumor-targeted corrole toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Photoexcitation of tumor-targeted corroles induces singlet oxygen-mediated augmentation of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Investigating photoexcitation-induced mitochondrial damage by chemotherapeutic corroles using multimode optical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.993374

10.1517/14712598.2015.993374

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference